For more years than I care to remember, I’ve been constantly on the go. Being ready and willing to take off on a moment’s notice, traipse through snake-infested rainforests, or even just stay up until three o’clock in the morning to speak with someone halfway around the world are some of the prices I’ve had to pay to be able to investigate health products and techniques firsthand. But the payoff—learning about new or unusual products years before the rest of the crowd—is incomparable to the hectic lifestyle. If there’s something out there, anywhere, that might help you or a loved one conquer a debilitating illness, I want you to know about it now, not one or two years down the road. By then it might be too late.
Through Alternatives, you’ve learned about and had access to some of the world’s most powerful therapies—shark cartilage, skin cancer creams, grapefruit seed extract, elderberry extract, coenzyme Q10—and dozens of other health solutions years before anyone else. And based on the myriad of research I’m currently working on, I can assure you this trend will continue. The information contained in this issue is a prime example.
I’ve recently uncovered what could be the most powerful immune system stimulant available today. In order to learn as much as I could about it, I had to track down a research scientist who "commutes" back and forth between Egypt and Japan. Trying to coordinate schedules to speak with him, particularly when I was in Australia this summer, was somewhat challenging to say the least. As you’ll see, though, it was definitely time well spent.
Simply knowing about this gentleman’s discovery and how to use it could one day save your life. I’m not exaggerating here—there’s really nothing else quite like it. And within a few years, I have a feeling you’ll be hearing a lot more about it in the more popular press...provided of course that it doesn’t get suppressed by the pharmaceutical giants or some federal agency (and that’s a big "if"). This one compound has the potential to change the way conventional medicine has approached health problems for the last 100 years.
As I’m sure you recall from history classes, Louis Pasteur (1822-1895) is credited with giving the world his theory that germs were the cause of disease. For almost 100 years now, conventional medicine has been based on Pasteur’s work. Researchers and doctors have operated under the belief that disease is caused by the invasion of germs, whether they be bacteria, viruses, parasites or fungi, and to eliminate disease these invading microbes have to be destroyed. In our continuing quest to eliminate these microbes, our medicines have become increasingly more potent. While this has led to a great deal of success in healing many infections, it has also exposed a number of germ theory’s shortcomings. As a result, many researchers are now rethinking the theory’s validity.
Over the years, two schools of thought concerning health and healing have emerged.
Conventional medicine and its disciples have accepted germ theory in its entirety—that the road to disease is paved with microbes, and to remain healthy these microbes must be eliminated. They believe this can best be accomplished through the use of drugs, particularly antibiotics.
The pharmaceutical industry absolutely loves this first idea. Sine there are literally millions of different microbes all around us, it stands to reason that thousands upon thousands of different medicines will be needed to destroy them. This translates into billions of dollars of profits, both from the sale of the drugs and the hundreds of testing procedures required to identify each of the pathogenic microbes involved.
The second school of thought opposes both the idea of using drugs to destroy microbes as well as the basic premise that microbes are the sole cause of disease. We live in an environment teeming with millions if not billions of microbes. These organisms inhabit and thrive in our air, water, soil and even in our bodies. Thanks to the delicate yet very complex actions of our immune system, we are able not only to survive but actually thrive in this microbe-infested environment. An active, healthy immune system is the one thing that keeps us alive.
Under normal circumstances, our immune systems are able to destroy harmful microbes while leaving benign varieties alone. Health problems, therefore, occur not simply because we’ve been exposed to one microbe or another, but because our immune systems are not functioning as well as they should be. This helps explain why not everyone exposed to the cold virus comes down with a cold, or why some people are able to avoid and recover from deadly diseases like cancer while others cannot.
When illness does take hold, followers of the second school of thought believe that emphasis should be placed on boosting the immune system through nutrition and other natural techniques. They recognize the importance of enhancing the body’s own innate healing powers through a proper diet and lifestyle.
To put it mildly, the pharmaceutical companies haven’t been too supportive of this latter idea. There’s not as much profit involved in promoting the use of whole, natural foods, herbs and vitamins as there is in selling drugs. As such, for years the pharmaceutical companies and many individuals within the medical profession have been trying to persuade the public that "alternatives" to drugs are a waste of time and money at best and outright quackery at worst. Recent trends and events have begun to prove them wrong.
Over the past few years, we have been witnessing the backlash of germ therapy in the form of deadly, antibiotic-resistant bacteria. As a result of being "attacked" by stronger and stronger antibiotics, several strains of bacteria have mutated and developed a resistance to all forms of medication currently available.
It should come as no surprise then that more and more people are dying of cancer each year. The toxic drug and radiation treatments heralded as the solution just aren’t working as expected. Similarly, AIDS researchers have determined that bombarding the body with anti-viral medications isn’t the answer. With AIDS, there are a number of different viruses at work (HIV,HHV-6B, etc) and developing a specific medication for each and every one could take decades or longer. To complicate matters even further, viral mutations occur quite rapidly and can quickly make a promising medication useless. And very often the side effects of these drug treatments prove to be far more deadly than the virus itself.
Be it AIDS, cancer or other deadly and seemingly incurable diseases, current research is confirming that therapies which hold the greatest promise are the more natural, less toxic ones that work in conjunction with the immune system.
A few short years ago, any comment about a substance’s ability to "boost the immune system" would have brought howls of laughter and condemnation from the medical community. Nowadays, however, this same concept seems to be all the rage among both traditional and conventional medical practitioners. Slowly but surely, modern medicine is beginning to understand the vital importance of enhancing the body’s own disease-fighting capabilities.
The work of one particular doctor, Dr Mamdooh Ghoneum, is undoubtedly going to awaken many in conventional medicine to the enormous benefits of using natural immune-enhancing compounds.
Dr Ghoneum works with the Department of Immunology at Drew University in Los Angeles. For the last six years he has been working on an amazing product called MGN-3. By reading this issue, you are among the first to ever hear about it. In fact, as far as I know, this is the first time the public has been told about MGN-3. Up until this article, the only published information about it has been buried in technical medical journals. When I first spoke with Dr Ghoneum, I asked him why. His answer may surprise you, as it did me.
Dr Ghoneum was educated in Egypt and Japan, and as I mentioned earlier he continues to spend much of his time in those countries. His work with MGN-3 began in Japan, where he is quite well-known. (He just finished his sixth book in Japanese, all of which deal with cancer.) As with most new therapies, his initial research was performed in vitro and later using animal models. Although the results were extremely positive, he refused to publicize the data until he was sure the similar results could be duplicated in humans. In a world where new fads based on just the slightest hint of benefit pop up almost daily, it’s refreshing and unusual to meet someone willing to forgo publicity in an effort to perform actual human studies. For this, Dr Ghoneum is to be highly commended.
Thanks to Dr Ghoneum, we now have excellent research data to show that MGN-3 is likely the most powerful human immune system booster on the market today, prescription or otherwise. Even most amazing is the fact that it has no known side effects. The implications this substance could have on your personal health are astounding.
MGN-3 is produced by integrating, through hydrolysis, an extract from the outer shell of rice bran with the extracts from three different mushrooms: Shiitake (yielding Lentinan), Kawaratake (yielding Krestin), and Suehirotake (yielding Sizofiran).
On their own, extracts from rice bran exhibit fairly strong antiviral effects. And extracts from each of these three mushrooms have been found to have anti-cancer properties. In fact, in Japan, these three mushroom extracts have become the three leading prescription treatments for cancer. In the years to come, I feel very strongly that mushrooms will become a primary source of natural medicines all over the world. Of the million or so known varieties, only a small handful have been categorized and analyzed. One of the challenges of using mushrooms medicinally is that they seem to work differently with different people. Fortunately, as I’ll explain later, the benefits MGN-3 provides the immune system are very consistent and predictable.
The human immune system is comprised of more than 130 subsets of white blood cells. In order to understand just how powerful an immune stimulator MGN-3 is and how you can use it to help treat a wide variety of serious health problems, you need some background information on one of the most common forms of white blood cells.
Natural Killer (NK) cells make up roughly 15% of all human white blood cells. They provide the first line of defense for dealing with any form of invasion to the body—sort of like elite military soldiers who are called upon to seek out and destroy dangerous invaders. Each cell contains several small granules which act as "ammunition." Once an NK cell has recognized a cancer cell, for example, it attaches itself to the cell’s outer membrane and injects these granules directly into the interior of the cell. The granules then "explode," destroying the cancer cell within five minutes. The undamaged NK cell then moves on to other cancer cells and repeats the process. When the immune system is particularly strong, active NK cells will often take on two cancer cells or other infected cells at the same time.
Unlike other white blood cells, inadequate numbers of NK cells are very rarely a problem. Instead, it is the activity of the cells that generally determines whether one is sick or healthy. As long as the NK cells are active (just soldiers remain on "active" duty, ready for battle), everything remains under control. If cells lose their ability to either recognize or destroy the invader, however, the situation can deteriorate rapidly. In AIDS and cancer patients, NK cell activity is probably the primary criteria for estimating the chances of survival. It’s pretty much accepted that when NK cells cease to function, the end is near.
In addition, research has now confirmed that individuals with low NK cell activity are significantly more susceptible to autoimmune diseases, chronic fatigue immune dysfunction (CFIDS or chronic fatigue syndrome), viral infections and the development of cancerous tumors. (I haven’t been able to verify that the same holds true in humans, but animal research has also shown that females commonly have lower NK cell activity than males.)
Doctors can test NK cell activity with a test called the NK cell function test. Basically, a blood sample is taken from the patient and placed in a vial containing live tumor cells. After four hours, a count is taken to determine what percentage of the cancer cells have been destroyed by the NK cells. The higher the percentage, the more active the cells.
(Technically, the test is referred to as the 4 hour 51Chromium-release assay. I’m certainly not advocating that everyone go out and have it done, but if you have been dealing with one of the conditions listed above or have had any sort of longstanding infection, it may be a good idea. If your local lab doesn’t perform the test, your doctor can order it from Specialty Labs in Santa Monica, CA at 800-421-7110.
MGN-3’s ability to boost NK activity and overall immunity appears to stem from four things.
1) First, as I mentioned earlier, MGN-3 increases the number of explosive granules in NK cells. The more granules an NK cell carries, the more cancer and virus-infected cells it can destroy.
2) MGN-3 increases interferon levels. Interferon is another potent compound produced by the body that both inhibits the replication of viruses and other parasites and increases NK cell activity.
3) MGN-3 increases the formation of Tumor Necrosis Factors (TNFs). TNFs are a group of proteins that help destroy cancer cells
4) In addition to increasing NK activity as much as 300% (or even higher), oral ingestion of MGN-3 can increase the activity of other key immune cells, like T-cells (200%) and B-cells (250%).
Dr Ghoneum’s years of research have proven just how powerful MGN-3 can be at boosting NK cell activity and combating a wide range of diseases. The majority of his work has been with cancer patients.
Unlike most forms of cancer treatment, MGN-3 is totally non-toxic. After years of use and continued toxicity tests, there have never been any indication of toxicity or side effects whatsoever. Undoubtedly, this is because MGN-3’s primary function is to enhance the activity of the immune system rather than to attack cancer cells directly. This also helps explain why it seems to work well for all types of cancer. Although huge amounts of data haven’t been published yet, MGN-3’s effects on human cancer patients have been very promising.
Dr Ghoneum’s latest study involved 24 cancer patients. First, doctors tested NK cell activity in each patient, and then administered the recommended cancer dosage of 3 grams per day of MGN-3. NK cell activity was tested again after 16 hours, one week, one month and two months.
After 16 hours, NK cell activity had increased 1.3 to 1.5 times. After one week, activity had increased eightfold. Activity continued to increase, and at the end of two months, the NK cells were killing 27 times more cancer cells in the four hour period than they were prior to take the MGN-3. (Int J Immunotherapy 98;XIV(2):89-99).
Dr Ghoneum told me that over the years he’s run numerous NK cell activity tests on patients with all types of cancers, and in 80 to 90% of those patients, their NK cells could only kill about 20 to 30% of the cancer cells during the first hour of the test. After just two weeks of taking MGN-3, however, the kill percentage jumped to 60 to 70% in 99% of the patients.
Dr Ghoneum presented the results from one of his studies involving five patients with breast cancer at the November 5, 1995, meeting of the American Association for Cancer Research. Each patient was treated with the same dosage of 3 grams per day of MGN-3. NK cell activity increased within two weeks and continued to do so as the study progressed. At the end of the six- to eight-month study, two of the patients were already in complete remission.
Another study of Dr Ghoneum’s involved 27 cancer patients ranging in age from 42 to 57. The types of cancers involved included breast, cervical, prostate, leukemia, and multiple myeloma. All patients had low NK cell activity at the beginning of the study. After only two weeks, the NK cell activity had increased as follows: breast carcinoma 154-332%, cervical carcinoma 100-275%, prostatic cancer 174-385%, leukemia 100-24-%, and multiple myeloma 100-537%. Remember, this was after just two weeks of MGN-3, and NK activity continued to rise throughout the six-month study. (Study reported at the 87th Annual Meeting of the American Association for Cancer Research, April 20, 1996.)
MGN-3 fills a gap left by many of the other natural therapies we’ve covered in the past, in particular, the class of therapies known as angiogenesis inhibitors.
Angiogenesis inhibitors, as you may recall from previous issues, work by cutting off the blood supply to tumors. Whether they be natural products like shark cartilage or pharmaceutical ones like endostatin and angiostatin, these angiogenesis inhibitors aren’t very effective at treating blood cancers such as leukemia, lymphatic cancer or lung cancer. In each case, the explanation for this ineffectiveness is fairly simple.
Because leukemia is a cancer of the blood cells themselves, cutting off the blood supply to these cells is simply impossible. With lymphatic cancer, it’s the lymphatic fluids, not blood vessels, that supply lymph cells with all of their necessary nutrients, so again, cutting off the blood supply is futile. And because the lungs have such a rich and complex supply of blood vessels, there’s really no effective way to restrict blood flow to that area.
None of these factors pose a problem for MGN-3. By increasing the activity of NK cells, which naturally reside and circulate in the blood and lymph systems, MGN-3 can be used effectively for all of these cancers. The NK cells don’t have to penetrate deep into massive hard tumors to get to active cancer cells—they simply identify and eliminate the cancer cells they "encounter" in the blood or lymph.
In another study involving 11 patients, the percentages of patients experiencing complete remission with MGN-3 were as follows:
1) Prostate cancer, two of the three patients or 66%. (Note: All of the prostate patients experienced a decline in PSA levels. One reached a normal level after one month on MGN-3, another’s was normal after two months and the third patient’s dropped from 87.2 to 7 after four months.)
2) Ovarian cancer, two of the three patients or 66%
3) Breast cancer, one of the three patients or 33%. (The other two had partial remission.)
4) Multiple myeloma, one of the two patients or 50%. (Int J Immunotherapy 95;XI(I):23-28).
While all of these results are impressive to say the least, the case of the multiple myeloma patient is particularly remarkable. Multiple myeloma is a very rare and fatal cancer. It makes up only about one percent of all cancers, and among oncology circles, it is considered practically incurable. Without treatment, a patient almost always lives less than a year. With chemotherapy, some have been known to live two years.
The multiple myeloma patient who experienced complete remission was 58-year-old male who was diagnosed in October of 1990. He first underwent several months of chemotherapy following his diagnosis. Although everything seemed to have stabilized, his laboratory work still showed specific blood markers for multiple myeloma eight months after the chemotherapy. He then began taking the MGN-3, and in less than six months follow-up, lab work revealed no indication of cancer. Today, almost eight years after his initial diagnosis, he continues to take MGN-3 and shows no signs of cancer. Dr Ghoneum told me that this is the first patient who has been known to survive multiple myeloma.
Above and beyond its own cancer-fighting abilities, MGN-3 lessens the toxic side effects of conventional cancer treatment. Both chemotherapy and radiation destroy many of the body’s white blood cells in the process of trying to destroy the cancer. Taking MGN-3 concurrently with these treatments can help prevent this effect. Many chemotherapy patients taking MGN-3 have also reported experiencing less difficulty in swallowing and less burning of the tongue.
In addition, MGN-3 has been used effectively with interleukin-2, the only prescription item that seems to come close to matching its immune-boosting power. (Although there are other natural products that have immune-boosting capabilities, none have been proven in human studies to be more powerful than MGN-3.)
Interleukin is a protein that is normally produced in the body. Much like MGN-3, it also activates certain white blood cells. To potentiate the effects of this protein, scientists isolated and synthesized it into a chemical called interleukin-2 (IL-2). This extract is then injected into patients to help stimulate their immune systems.
Although IL-2 is gaining popularity as a cancer treatment, it can trigger extremely severe and life-threatening side effects. At the therapeutic doses used for cancer, interleukin-2 causes leaks in the small capillaries. These leaks result in a loss of blood pressure, weight gain, fluid retention, difficulty breathing and heart problems. Continued use can cause kidney failure, respiratory arrest and death. In this way, it represents yet another cancer treatment that often kills the patient before it kills the cancer. Expense is also a factor. A single interleukin-2 treatment can cost as much as $100,000.
Dr Ghoneum’s research has revealed that when MGN-3 is used along with interleukin-2, the dosages of interleukin-2 can be reduced to extremely low levels—levels which are low enough to avoid the severe side effects. When used together, these two products have a synergistic effect that dramatically exceeds that of either used individually. Once this knowledge becomes public (beyond this article, I mean), I hope more oncologists will be doing work in this area. I will personally be keeping a close eye on any additional research that develops and, as always, keep you informed in the months to come.
Another of Dr Ghoneusm’s studies involved seven female patients whose pap smears indicated the presence of abnormal cells. This is not an uncommon finding, and while these cells are not cancerous, they are often referred to as pre-cancerous because of their propensity to develop into cervical cancer.
The severity of cervical dysplasia, as the problem is termed medically, is classified in four stages depending on the degree of abnormality in the cells. Stage I is generally a "wait-and-watch" situation, stages II and III are considered surgical cases, and stage IV is considered cancer.
In the above study, Dr Ghoneum found that using MGN-3 is stage II and stage III patients completely resolved the problem. After six months of MGN-3 use, with no other form of treatment, all follow-up exams and tests were normal. Some of the women have continued on maintenance doses of MGN-3 at 1 gram per day. Others have discontinued its use. Today, two to three years after the study, none of the women has experienced recurrence, including women who discontinued the product after only six months.
(Over a decade ago, in Vol 1, No 21, I wrote about how high doses of folic acid (10 milligrams a day) could also be used for cervical dysplasia. I would certainly recommend following the guidelines I outlined in that issue, in addition to those I will outline for MGN-s, when treating such problems.)
Over the years, Dr Ghoneum has worked with several HIV-infected patients. During the normal progression of this disease, NK cell activity begins to drop along with other immune cells called CD4s and CD8s. CD4 levels routinely decrease at a rate of about 15% a year. In patients taking MGN-3 however, Dr Ghoneum says the CD4 levels can be maintained in almost every case, and oftentimes they will even begin to increase.
Work with AIDS patients has been limited, although all of the patients who have taken MGN-3 reported a noticeable difference in their well-being, and all have continued to use the product. Most felt MGN-3 was instrumental in helping them stabilize their disease.
Although laboratory work has confirmed that MGN-3 inhibits the replication of HIV, it is definitely not the total answer to the problem. Over the years, I have reported on a number of therapies that seem to ameliorate the effects of the virus, but it remains clear that more research needs to be done in this area. (Biochem Biophys Res Commun 98;243:25-29).
Although he has not yet published the results, Dr Ghoneum recently shared with me his extraordinary results using MGN-3 to treat viral hepatitis, varieties B and C.
Within one week to a month of taking the product, all of the patients had experienced a significant decrease in their symptoms. Laboratory tests for enzyme levels have shown that liver function begins to improve within two weeks. And after four to five months, everything shows up as normal. Dr Ghoneum has been following one particular hepatitis patient for almost two years now, and the patient has not experienced any relapse nor any further problems. The patient continues to take the daily maintenance dosage of the MGN-3 (1 gram per day).
Dr Ghoneum has performed an amazing amount of valuable research in just the last six or seven years. When I last spoke with him, he expressed eagerness to investigate MGN-3’s therapeutic potential with many other conditions, but in light of his limited time and research funding, he’s had to concentrate his efforts on life-saving areas like cancer and AIDS. Based on what he has already uncovered, however, it is clear that his product holds great promise for many other conditions.
Earlier, I cited chronic fatigue syndrome as one of those conditions. Additionally, MGN-3 could prove to be a lifesaver when it comes to any chronic or severe bacterial, viral or fungal infection.
Dr Ghoneum has defined what he calls "high risk" categories, and he believes that individuals in these categories could also benefit from MGN-3 mainly as a form of disease prevention.
Included in these would be:
· Heavy smokers (those smoking two packs or more per day)
· Heavy drinkers
· Individuals who constantly work with paint (artists, house painters, etc)
· Individuals born with immune deficiencies
· Families with a strong history of cancer
· Chemical and refinery workers
The dosages Dr Ghoneum has used in his studies are scientifically based on repeated NK cell activity tests. As such, they are very consistent and easy to follow. They fall into two categories.
1) For cancer, HIV or other life-threatening condition, 3 grams per day for two weeks, then 1 gram per day until the problem is resolved. Some of the people Dr Ghoneum has worked with continue to take the maintenance dosage even after the problem has been resolved, while others stop taking it and resume if the problem returns.
2) As a form of prevention, 1 gram per day.
Just to reiterate, MGN-3 is completely non-toxic and there’s no danger whatsoever in taking it long-term. Many people stay on it for life.
In all of his studies, Dr Ghoneum found that taking 3 grams a day resulted in a dramatic increase in NK cell activity within one to two weeks. At the lower dosage of only 1 gram per day, the same activity wasn’t reached until about four weeks. This explains the initial heavy doses of 3 grams per day. Even after the dosage is dropped back to 1 gram per day, NK cell activity will continue to increase.
It is best to take the MGN-3 capsules with meals in divided doses. For example, when taking 3 grams a day (which works out to 12 capsules), 4 capsules can be taken with each meal. When you drop down to 1 gram a day (4 capsules), you can take two capsules at breakfast and two at dinner.
In the United States, MGN-3 is marketed exclusively by Lane Labs and is available through select distributors of quality vitamins and natural supplements.
The price of this product is on the expensive side compared to ordinary supplements, but certainly not compared to prescription medications or treatments.
Pat McKay, Inc: A 50-capsule bottle (250 milligrams per capsule) has a retail price of $69.95.
Based on his research and experience, I asked Dr Ghoneum for his opinions on the treatment of cancer and what he would do if he were diagnosed with the disease. (I would like to acknowledge up front that Dr Ghoneum shared the following terrorist analogy with me prior to the US military taking action against terrorists in the Middle East. While I considered removing this section for "political" reasons, the fact remains that the analogy works, and I want you to read it just as Dr Ghoneum explained it to me.)
Depending on the type and location of the cancer, Dr Ghoneum believes that surgery or a few cycles of chemotherapy or radiation therapy would be justified. He compared treating cancer to trying to wipe out a city of terrorists. By bombing the city, you would likely take care of the majority of the terrorists, accepting the fact that some non-terrorists would also be killed. Chemotherapy, radiation or surgical removal of the tumor are the cancer-equivalents of the bombing, and the beneficial white blood cells in the area are the non-terrorist victims.
Even after the bombing, however, there would always be some terrorists who could survive. The same holds true for cancer cells that were resistant to or able to survive the therapy. But rather than bomb the city again, which would only result in total destruction, special forces should be sent in to locate and eliminate the remaining terrorists one by one. This is where MGN-3 comes in. Dr Ghoneum feels that after surgery or a minimal number of chemo or radiation treatments, MGN-3 should be used exclusively to activate the immune system and let it do its work. (He also clarified that he would begin using the MGN-3 at the very first sign of any type of cancer, not just after conventional treatments had been completed.)
Dr Ghoneum had some strong opinions regarding the use of any drugs or nutritional products during the treatment period. For all of the people he’s worked with, he recommended that only necessary prescription drugs be continued (such as those for diabetes, high blood pressure, thyroid, etc). In addition, because his research did not examine the combined effects of nutritional supplements and MGN-3, he recommended that patients concentrate on getting vitamins and minerals solely from natural foods and juices (organic carrots and other freshly made fruit and vegetable juices).
Pat McKay: That is why our Calcium+Plus, AnimaLife, C+Plus, and Lifestar Vitamin E, are all right to give, because they are all Living Food Concentrates. The body recognizes them as food!
Through his work with the immune system, Dr Ghoneum has also found that poor sleeping habits and unresolved stress have a major negative impact on the activity of NK cells. He felt very strongly that both of these problems must be addressed if one expects to strengthen the immune system. (It was just last month that we revisited the importance of proper sleep in this newsletter. If you haven’t taken the seven steps that I outlined, you may want to make that tonight’s bedside reading.)
In many of these regards, I agree with Dr Ghoneum. If diagnosed with cancer, I too would begin a diet largely comprised of fresh juices and would make extra efforts to reduce the amount of stress in my life. I would also begin taking MGN-3 immediately.
However, I cannot say that I endorse the use of chemotherapy and radiation. I have met people who have been helped by it, and I have watched others waste away because of it. Nor can I say that I would cease taking nutritional supplements. It is more likely that I would increase my intake of particular nutrients and, depending on the type of cancer, begin taking cancer-specific supplements like shark cartilage. The past 13 years of this newsletter are packed with research on the cancer-fighting potential of dozens of different natural substances, and I cannot imagine turning my back on such conclusive evidence.
In all of my years writing Alternative, this issue stands out in my mind as one of the most significant. The discovery of MGN-3 comes at a time when we need it most. Our health is under assault from practically every angle these days, and we now know that our best defense is to boost the inner workings of the immune system. MGN-3 gives us a safe and effective way of doing just that. It is the most powerful immune stimulant man has uncovered thus far, and it may be our best hope in conquering the world’s deadliest diseases.
If MGN-3 were a drug, it would be front-page news. It would be the top story on every newscast in the country. Doctors would now be prescribing it as an adjunctive therapy for most major diseases, and pharmaceutical companies would be making billions off of it. But MGN-3 isn’t a drug, and it probably won’t make the news, and it could even threaten the multi-billion dollar profits of the US drug industry. It may even get jerked off the market. That’s why you’re learning about it here in Alternatives. It’s the discovery of substances like MGN-3 that keeps me doing what I do. And it’s the promise of even greater solutions that inspires me to continue to dedicate my life, my savings, and my heart to this exploration for many years to come.
Dr David Williams
Dr David Williams has dedicated his life to conducting first-hand research around the world on promising new therapies such as MGN-3. He is the editor of Alternatives, a monthly newsletter published since 1985 that brings to consumers and medical professionals the most up-to-date research on safe and effective therapies for a wide range of health conditions. If you’d like to receive Dr Williams’ breakthrough research on a regular basis, subscriptions to Alternatives are available for $39.95 per years. Call 800-219-8591 and mention code ALTLAN.